Jan 08, 2018 12:01 pm UTC| Business
DUBLIN, Ireland, Jan. 08, 2018 -- Horizon Pharma plc (NASDAQ:HZNP), today announced that it has licensed the global rights to MEDI4945, a pre-clinical, genetically engineered uricase derivative combined with...
SemGroup Corporation to Sell Mexican Asphalt Business for $70 Million
Jan 08, 2018 12:01 pm UTC| Business
TULSA, Okla., Jan. 08, 2018 -- SemGroup® Corporation (NYSE:SEMG) today announced that it has reached an agreement to sell its asphalt business, SemMaterials México, to Ergon Asfaltos México HC, LLC, for an estimated $70...
Jan 08, 2018 12:01 pm UTC| Business
LEIDEN, the Netherlands, Jan. 08, 2018 -- ProQR Therapeutics N.V. (NASDAQ:PRQR), today announced that it has entered into a research collaboration agreement with Galapagos N.V. (Euronext NASDAQ:GLPG). Under the...
Amarillo Appoints Mike Mutchler as President and CEO
Jan 08, 2018 12:01 pm UTC| Business
TORONTO, Jan. 08, 2018 -- Amarillo Gold Corporation (“Amarillo” or the “Company”) (TSX.V:AGC), is pleased to announce the appointment of Mike Mutchler as President CEO and Director of the Company effective immediately....
Jan 08, 2018 12:01 pm UTC| Business
Highly statistically significant results on all primary and secondary endpointsStatistical significance seen as early as day 28, after 4 weeks of treatment in WART-203If approved, A-101 45% would be the first FDA approved...
AxoGen, Inc. Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue
Jan 08, 2018 12:01 pm UTC| Business
Q4 Revenue will be at least $16.5 million, representing 45% growth over prior year2017 Revenue will be at least $60.0 million, representing 46% growth over prior year ALACHUA, Fla., Jan. 08, 2018 -- AxoGen, Inc....
Delta Apparel Announces Preliminary First Quarter Results
Jan 08, 2018 12:01 pm UTC| Business
GREENVILLE, S.C., Jan. 08, 2018 -- Delta Apparel, Inc. (NYSE American:DLA), a leading provider of basic and branded apparel, headwear and related accessories, today announced preliminary results for its 2018 fiscal...